TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
OptiBiotix Health ( (GB:OPTI) ) has shared an update.
OptiBiotix Health plc has issued 358,772 options over new ordinary shares to Director Sofia Kolyda, with an exercise price of 11 pence per share. The options, which expire in 2035, are part of the company’s strategic initiatives to incentivize leadership and align with its commercial goals, particularly in securing significant revenue-generating partnerships for its SweetBiotix products.
More about OptiBiotix Health
OptiBiotix Health plc, established in March 2012, is a life sciences company focused on developing compounds that modify the human microbiome to prevent and manage diseases and promote wellness. The company collaborates with international food and healthcare supplement companies to incorporate its microbiome modulators into various food products and drinks, with a focus on areas such as obesity, cardiovascular health, and diabetes.
Average Trading Volume: 316,539
Technical Sentiment Signal: Sell
Current Market Cap: £11.62M
See more data about OPTI stock on TipRanks’ Stock Analysis page.